Hemgenix continues to be supplied ‘conditional authorisation’. This means that the European Medicines Agency decided that the advantages of Hemgenix are greater than its challenges, but the business will have to offer additional proof immediately after authorisation. According to the scientific specialists consulted by CADTH, there are many unmet needs https://nilese568srp8.bloggazza.com/profile